 Bicycle Therapeutics plc NASDAQ:BCYC, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide Bicycles technology, today reported financial results for the first quarter ended March 31, 2020 and discussed recent corporate updates. 